<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1994-02-01" modified="2018-01-31" version="218">
<accession>Q06124</accession>
<accession>A8K1D9</accession>
<accession>Q96HD7</accession>
<name>PTN11_HUMAN</name>
<protein>
<recommendedName>
<fullName>Tyrosine-protein phosphatase non-receptor type 11</fullName>
<ecNumber evidence="74 75">3.1.3.48</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Protein-tyrosine phosphatase 1D</fullName>
<shortName>PTP-1D</shortName>
</alternativeName>
<alternativeName>
<fullName>Protein-tyrosine phosphatase 2C</fullName>
<shortName>PTP-2C</shortName>
</alternativeName>
<alternativeName>
<fullName>SH-PTP2</fullName>
<shortName>SHP-2</shortName>
<shortName>Shp2</shortName>
</alternativeName>
<alternativeName>
<fullName>SH-PTP3</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">PTPN11</name>
<name type="synonym">PTP2C</name>
<name type="synonym">SHPTP2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1992" name="FEBS Lett." volume="314" first="335" last="339">
<title>Molecular cloning of a novel protein-tyrosine phosphatase SH-PTP3 with sequence similarity to the src-homology region 2.</title>
<authorList>
<person name="Adachi M."/>
<person name="Sekiya M."/>
<person name="Miyachi T."/>
<person name="Matsuno K."/>
<person name="Hinoda Y."/>
<person name="Imai K."/>
<person name="Yachi A."/>
</authorList>
<dbReference type="PubMed" id="1281790"/>
<dbReference type="DOI" id="10.1016/0014-5793(92)81500-L"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>T-cell</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1992" name="Proc. Natl. Acad. Sci. U.S.A." volume="89" first="11239" last="11243">
<title>Identification of a human src homology 2-containing protein-tyrosine-phosphatase: a putative homolog of Drosophila corkscrew.</title>
<authorList>
<person name="Freeman R.M. Jr."/>
<person name="Plutzky J."/>
<person name="Neel B.G."/>
</authorList>
<dbReference type="PubMed" id="1280823"/>
<dbReference type="DOI" id="10.1073/pnas.89.23.11239"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1993" name="Biochem. Biophys. Res. Commun." volume="196" first="124" last="133">
<title>Cloning, expression and mutational analysis of SH-PTP2, human protein-tyrosine phosphatase.</title>
<authorList>
<person name="Bastien L."/>
<person name="Ramachandran C."/>
<person name="Liu S."/>
<person name="Adam M."/>
</authorList>
<dbReference type="PubMed" id="8216283"/>
<dbReference type="DOI" id="10.1006/bbrc.1993.2224"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>MUTAGENESIS OF CYS-463</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1993" name="Proc. Natl. Acad. Sci. U.S.A." volume="90" first="2197" last="2201">
<title>A widely expressed human protein-tyrosine phosphatase containing src homology 2 domains.</title>
<authorList>
<person name="Ahmad S."/>
<person name="Banville D.L."/>
<person name="Zhao Z."/>
<person name="Fischer E.H."/>
<person name="Shen S.H."/>
</authorList>
<dbReference type="PubMed" id="7681589"/>
<dbReference type="DOI" id="10.1073/pnas.90.6.2197"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Umbilical cord</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1993" name="Science" volume="259" first="1611" last="1614">
<title>Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation.</title>
<authorList>
<person name="Vogel W."/>
<person name="Lammers R."/>
<person name="Huang J."/>
<person name="Ullrich A."/>
</authorList>
<dbReference type="PubMed" id="7681217"/>
<dbReference type="DOI" id="10.1126/science.7681217"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="6">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="8">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)</scope>
<source>
<tissue>Eye</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="21478" last="21481">
<title>Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor.</title>
<authorList>
<person name="Lechleider R.J."/>
<person name="Sugimoto S."/>
<person name="Bennett A.M."/>
<person name="Kashishian A.S."/>
<person name="Cooper J.A."/>
<person name="Shoelson S.E."/>
<person name="Walsh C.T."/>
<person name="Neel B.G."/>
</authorList>
<dbReference type="PubMed" id="7691811"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH PDGFRB</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1994" name="Proc. Natl. Acad. Sci. U.S.A." volume="91" first="7335" last="7339">
<title>Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor beta to Ras.</title>
<authorList>
<person name="Bennett A.M."/>
<person name="Tang T.L."/>
<person name="Sugimoto S."/>
<person name="Walsh C.T."/>
<person name="Neel B.G."/>
</authorList>
<dbReference type="PubMed" id="8041791"/>
<dbReference type="DOI" id="10.1073/pnas.91.15.7335"/>
</citation>
<scope>PHOSPHORYLATION BY PDGFRB</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="25569" last="25574">
<title>Activation of protein-tyrosine phosphatase SH-PTP2 by a tyrosine-based activation motif of a novel brain molecule.</title>
<authorList>
<person name="Ohnishi H."/>
<person name="Kubota M."/>
<person name="Ohtake A."/>
<person name="Sato K."/>
<person name="Sano S."/>
</authorList>
<dbReference type="PubMed" id="8810330"/>
<dbReference type="DOI" id="10.1074/jbc.271.41.25569"/>
</citation>
<scope>INTERACTION WITH PTPNS1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1997" name="Nature" volume="386" first="181" last="186">
<title>A family of proteins that inhibit signalling through tyrosine kinase receptors.</title>
<authorList>
<person name="Kharitonenkov A."/>
<person name="Chen Z."/>
<person name="Sures I."/>
<person name="Wang H."/>
<person name="Schilling J."/>
<person name="Ullrich A."/>
</authorList>
<dbReference type="PubMed" id="9062191"/>
<dbReference type="DOI" id="10.1038/386181a0"/>
</citation>
<scope>INTERACTION WITH PTPNS1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1998" name="Biochem. Biophys. Res. Commun." volume="246" first="95" last="99">
<title>Tyrosine 1213 of Flt-1 is a major binding site of Nck and SHP-2.</title>
<authorList>
<person name="Igarashi K."/>
<person name="Isohara T."/>
<person name="Kato T."/>
<person name="Shigeta K."/>
<person name="Yamano T."/>
<person name="Uno I."/>
</authorList>
<dbReference type="PubMed" id="9600074"/>
<dbReference type="DOI" id="10.1006/bbrc.1998.8578"/>
</citation>
<scope>INTERACTION WITH FLT1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1999" name="Blood" volume="93" first="1809" last="1816">
<title>Gab-family adapter proteins act downstream of cytokine and growth factor receptors and T- and B-cell antigen receptors.</title>
<authorList>
<person name="Nishida K."/>
<person name="Yoshida Y."/>
<person name="Itoh M."/>
<person name="Fukada T."/>
<person name="Ohtani T."/>
<person name="Shirogane T."/>
<person name="Atsumi T."/>
<person name="Takahashi-Tezuka M."/>
<person name="Ishihara K."/>
<person name="Hibi M."/>
<person name="Hirano T."/>
</authorList>
<dbReference type="PubMed" id="10068651"/>
</citation>
<scope>INTERACTION WITH GAB2</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1999" name="J. Exp. Med." volume="189" first="1181" last="1194">
<title>SHP2-interacting transmembrane adaptor protein (SIT), a novel disulfide-linked dimer regulating human T-cell activation.</title>
<authorList>
<person name="Marie-Cardine A."/>
<person name="Kirchgessner H."/>
<person name="Bruyns E."/>
<person name="Shevchenko A."/>
<person name="Mann M."/>
<person name="Autschbach F."/>
<person name="Ratnofsky S."/>
<person name="Meuer S."/>
<person name="Schraven B."/>
</authorList>
<dbReference type="PubMed" id="10209036"/>
<dbReference type="DOI" id="10.1084/jem.189.8.1181"/>
</citation>
<scope>INTERACTION WITH SIT1</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2000" name="Nat. Cell Biol." volume="2" first="62" last="69">
<title>Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation.</title>
<authorList>
<person name="Miao H."/>
<person name="Burnett E."/>
<person name="Kinch M."/>
<person name="Simon E."/>
<person name="Wang B."/>
</authorList>
<dbReference type="PubMed" id="10655584"/>
<dbReference type="DOI" id="10.1038/35000008"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH EPHA2</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="5453" last="5459">
<title>Dissecting the interaction of SHP-2 with PZR, an immunoglobulin family protein containing immunoreceptor tyrosine-based inhibitory motifs.</title>
<authorList>
<person name="Zhao R."/>
<person name="Zhao Z.J."/>
</authorList>
<dbReference type="PubMed" id="10681522"/>
<dbReference type="DOI" id="10.1074/jbc.275.8.5453"/>
</citation>
<scope>INTERACTION WITH MZPL1</scope>
<scope>DEPHOSPHORYLATION OF MZPL1</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2001" name="Biochem. Biophys. Res. Commun." volume="280" first="768" last="775">
<title>Molecular cloning and characterization of SPAP1, an inhibitory receptor.</title>
<authorList>
<person name="Xu M.-J."/>
<person name="Zhao R."/>
<person name="Zhao Z.J."/>
</authorList>
<dbReference type="PubMed" id="11162587"/>
<dbReference type="DOI" id="10.1006/bbrc.2000.4213"/>
</citation>
<scope>INTERACTION WITH FCRL3</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2001" name="Blood" volume="97" first="3867" last="3874">
<title>Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP.</title>
<authorList>
<person name="Sayos J."/>
<person name="Martin M."/>
<person name="Chen A."/>
<person name="Simarro M."/>
<person name="Howie D."/>
<person name="Morra M."/>
<person name="Engel P."/>
<person name="Terhorst C."/>
</authorList>
<dbReference type="PubMed" id="11389028"/>
<dbReference type="DOI" id="10.1182/blood.V97.12.3867"/>
</citation>
<scope>INTERACTION WITH CD84</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2001" name="Clin. Immunol." volume="100" first="15" last="23">
<title>Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family.</title>
<authorList>
<person name="Lewis J."/>
<person name="Eiben L.J."/>
<person name="Nelson D.L."/>
<person name="Cohen J.I."/>
<person name="Nichols K.E."/>
<person name="Ochs H.D."/>
<person name="Notarangelo L.D."/>
<person name="Duckett C.S."/>
</authorList>
<dbReference type="PubMed" id="11414741"/>
<dbReference type="DOI" id="10.1006/clim.2001.5035"/>
</citation>
<scope>INTERACTION WITH CD84</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2001" name="Eur. J. Immunol." volume="31" first="1825" last="1836">
<title>Structural and functional dissection of the cytoplasmic domain of the transmembrane adaptor protein SIT (SHP2-interacting transmembrane adaptor protein).</title>
<authorList>
<person name="Pfrepper K.-I."/>
<person name="Marie-Cardine A."/>
<person name="Simeoni L."/>
<person name="Kuramitsu Y."/>
<person name="Leo A."/>
<person name="Spicka J."/>
<person name="Hilgert I."/>
<person name="Scherer J."/>
<person name="Schraven B."/>
</authorList>
<dbReference type="PubMed" id="11433379"/>
<dbReference type="DOI" id="10.1002/1521-4141(200106)31:6&lt;1825::AID-IMMU1825>3.0.CO;2-V"/>
</citation>
<scope>INTERACTION WITH SIT1</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2003" name="Mol. Biol. Cell" volume="14" first="3553" last="3564">
<title>Identification of Fer tyrosine kinase localized on microtubules as a platelet endothelial cell adhesion molecule-1 phosphorylating kinase in vascular endothelial cells.</title>
<authorList>
<person name="Kogata N."/>
<person name="Masuda M."/>
<person name="Kamioka Y."/>
<person name="Yamagishi A."/>
<person name="Endo A."/>
<person name="Okada M."/>
<person name="Mochizuki N."/>
</authorList>
<dbReference type="PubMed" id="12972546"/>
<dbReference type="DOI" id="10.1091/mbc.E03-02-0080"/>
</citation>
<scope>INTERACTION WITH FER AND PECAM1</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2003" name="Proc. Natl. Acad. Sci. U.S.A." volume="100" first="13489" last="13494">
<title>The inhibitory potential of Fc receptor homolog 4 on memory B cells.</title>
<authorList>
<person name="Ehrhardt G.R.A."/>
<person name="Davis R.S."/>
<person name="Hsu J.T."/>
<person name="Leu C.-M."/>
<person name="Ehrhardt A."/>
<person name="Cooper M.D."/>
</authorList>
<dbReference type="PubMed" id="14597715"/>
<dbReference type="DOI" id="10.1073/pnas.1935944100"/>
</citation>
<scope>INTERACTION WITH FCRL4</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2004" name="Cell. Mol. Life Sci." volume="61" first="2535" last="2548">
<title>Signal transduction via the stem cell factor receptor/c-Kit.</title>
<authorList>
<person name="Ronnstrand L."/>
</authorList>
<dbReference type="PubMed" id="15526160"/>
<dbReference type="DOI" id="10.1007/s00018-004-4189-6"/>
</citation>
<scope>REVIEW ON ROLE IN KIT SIGNALING</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="27088" last="27097">
<title>Activation of vascular endothelial growth factor receptor-3 and its downstream signaling promote cell survival under oxidative stress.</title>
<authorList>
<person name="Wang J.F."/>
<person name="Zhang X."/>
<person name="Groopman J.E."/>
</authorList>
<dbReference type="PubMed" id="15102829"/>
<dbReference type="DOI" id="10.1074/jbc.M314015200"/>
</citation>
<scope>INTERACTION WITH FLT4</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2005" name="Nat. Biotechnol." volume="23" first="94" last="101">
<title>Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.</title>
<authorList>
<person name="Rush J."/>
<person name="Moritz A."/>
<person name="Lee K.A."/>
<person name="Guo A."/>
<person name="Goss V.L."/>
<person name="Spek E.J."/>
<person name="Zhang H."/>
<person name="Zha X.-M."/>
<person name="Polakiewicz R.D."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="15592455"/>
<dbReference type="DOI" id="10.1038/nbt1046"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2006" name="Biochim. Biophys. Acta" volume="1762" first="828" last="834">
<title>ANKHD1, ankyrin repeat and KH domain containing 1, is overexpressed in acute leukemias and is associated with SHP2 in K562 cells.</title>
<authorList>
<person name="Traina F."/>
<person name="Favaro P.M.B."/>
<person name="Medina Sde S."/>
<person name="Duarte Ada S."/>
<person name="Winnischofer S.M."/>
<person name="Costa F.F."/>
<person name="Saad S.T.O."/>
</authorList>
<dbReference type="PubMed" id="16956752"/>
<dbReference type="DOI" id="10.1016/j.bbadis.2006.07.010"/>
</citation>
<scope>INTERACTION WITH ANKHD1</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2006" name="Cancer Res." volume="66" first="7473" last="7481">
<title>ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice.</title>
<authorList>
<person name="Charest A."/>
<person name="Wilker E.W."/>
<person name="McLaughlin M.E."/>
<person name="Lane K."/>
<person name="Gowda R."/>
<person name="Coven S."/>
<person name="McMahon K."/>
<person name="Kovach S."/>
<person name="Feng Y."/>
<person name="Yaffe M.B."/>
<person name="Jacks T."/>
<person name="Housman D."/>
</authorList>
<dbReference type="PubMed" id="16885344"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-06-1193"/>
</citation>
<scope>INTERACTION WITH ROS1</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2007" name="Blood" volume="109" first="3786" last="3793">
<title>FcRL6, a new ITIM-bearing receptor on cytolytic cells, is broadly expressed by lymphocytes following HIV-1 infection.</title>
<authorList>
<person name="Wilson T.J."/>
<person name="Presti R.M."/>
<person name="Tassi I."/>
<person name="Overton E.T."/>
<person name="Cella M."/>
<person name="Colonna M."/>
</authorList>
<dbReference type="PubMed" id="17213291"/>
<dbReference type="DOI" id="10.1182/blood-2006-06-030023"/>
</citation>
<scope>INTERACTION WITH FCRL6</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="33155" last="33161">
<title>Nuclear protein tyrosine phosphatase Shp-2 is one important negative regulator of nuclear export of telomerase reverse transcriptase.</title>
<authorList>
<person name="Jakob S."/>
<person name="Schroeder P."/>
<person name="Lukosz M."/>
<person name="Buchner N."/>
<person name="Spyridopoulos I."/>
<person name="Altschmied J."/>
<person name="Haendeler J."/>
</authorList>
<dbReference type="PubMed" id="18829466"/>
<dbReference type="DOI" id="10.1074/jbc.M805138200"/>
</citation>
<scope>INTERACTION WITH TERT</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2008" name="J. Cell Biol." volume="181" first="999" last="1012">
<title>Regulation of RhoA-dependent ROCKII activation by Shp2.</title>
<authorList>
<person name="Lee H.H."/>
<person name="Chang Z.F."/>
</authorList>
<dbReference type="PubMed" id="18559669"/>
<dbReference type="DOI" id="10.1083/jcb.200710187"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2008" name="Nat. Immunol." volume="9" first="898" last="907">
<title>An essential function for beta-arrestin 2 in the inhibitory signaling of natural killer cells.</title>
<authorList>
<person name="Yu M.-C."/>
<person name="Su L.-L."/>
<person name="Zou L."/>
<person name="Liu Y."/>
<person name="Wu N."/>
<person name="Kong L."/>
<person name="Zhuang Z.-H."/>
<person name="Sun L."/>
<person name="Liu H.P."/>
<person name="Hu J.-H."/>
<person name="Li D."/>
<person name="Strominger J.L."/>
<person name="Zang J.-W."/>
<person name="Pei G."/>
<person name="Ge B.-X."/>
</authorList>
<dbReference type="PubMed" id="18604210"/>
<dbReference type="DOI" id="10.1038/ni.1635"/>
</citation>
<scope>INTERACTION WITH KIR2DL1</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT THR-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="20206" last="20214">
<title>GAREM, a novel adaptor protein for growth factor receptor-bound protein 2, contributes to cellular transformation through the activation of extracellular signal-regulated kinase signaling.</title>
<authorList>
<person name="Tashiro K."/>
<person name="Tsunematsu T."/>
<person name="Okubo H."/>
<person name="Ohta T."/>
<person name="Sano E."/>
<person name="Yamauchi E."/>
<person name="Taniguchi H."/>
<person name="Konishi H."/>
</authorList>
<dbReference type="PubMed" id="19509291"/>
<dbReference type="DOI" id="10.1074/jbc.M109.021139"/>
</citation>
<scope>INTERACTION WITH GAREM1</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2009" name="J. Immunol." volume="182" first="5041" last="5051">
<title>A novel and critical role for tyrosine 663 in platelet endothelial cell adhesion molecule-1 trafficking and transendothelial migration.</title>
<authorList>
<person name="Dasgupta B."/>
<person name="Dufour E."/>
<person name="Mamdouh Z."/>
<person name="Muller W.A."/>
</authorList>
<dbReference type="PubMed" id="19342684"/>
<dbReference type="DOI" id="10.4049/jimmunol.0803192"/>
</citation>
<scope>INTERACTION WITH PECAM1</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2009" name="J. Immunol." volume="183" first="5502" last="5510">
<title>FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling.</title>
<authorList>
<person name="Kochi Y."/>
<person name="Myouzen K."/>
<person name="Yamada R."/>
<person name="Suzuki A."/>
<person name="Kurosaki T."/>
<person name="Nakamura Y."/>
<person name="Yamamoto K."/>
</authorList>
<dbReference type="PubMed" id="19843936"/>
<dbReference type="DOI" id="10.4049/jimmunol.0901982"/>
</citation>
<scope>INTERACTION WITH FCRL3</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-62 AND TYR-584</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="2010" name="Cell. Signal." volume="22" first="1363" last="1368">
<title>Mutation of tyrosine residue 857 in the PDGF beta-receptor affects cell proliferation but not migration.</title>
<authorList>
<person name="Wardega P."/>
<person name="Heldin C.H."/>
<person name="Lennartsson J."/>
</authorList>
<dbReference type="PubMed" id="20494825"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2010.05.004"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH PDGFRB</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2010" name="PLoS Genet." volume="6" first="E1000991" last="E1000991">
<title>Whole-genome sequencing of a single proband together with linkage analysis identifies a Mendelian disease gene.</title>
<authorList>
<person name="Sobreira N.L."/>
<person name="Cirulli E.T."/>
<person name="Avramopoulos D."/>
<person name="Wohler E."/>
<person name="Oswald G.L."/>
<person name="Stevens E.L."/>
<person name="Ge D."/>
<person name="Shianna K.V."/>
<person name="Smith J.P."/>
<person name="Maia J.M."/>
<person name="Gumbs C.E."/>
<person name="Pevsner J."/>
<person name="Thomas G."/>
<person name="Valle D."/>
<person name="Hoover-Fong J.E."/>
<person name="Goldstein D.B."/>
</authorList>
<dbReference type="PubMed" id="20577567"/>
<dbReference type="DOI" id="10.1371/journal.pgen.1000991"/>
</citation>
<scope>INVOLVEMENT IN MC</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="42">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2012" name="Sci. Signal." volume="5" first="RA78" last="RA78">
<title>Mice lacking the ITIM-containing receptor G6b-B exhibit macrothrombocytopenia and aberrant platelet function.</title>
<authorList>
<person name="Mazharian A."/>
<person name="Wang Y.J."/>
<person name="Mori J."/>
<person name="Bem D."/>
<person name="Finney B."/>
<person name="Heising S."/>
<person name="Gissen P."/>
<person name="White J.G."/>
<person name="Berndt M.C."/>
<person name="Gardiner E.E."/>
<person name="Nieswandt B."/>
<person name="Douglas M.R."/>
<person name="Campbell R.D."/>
<person name="Watson S.P."/>
<person name="Senis Y.A."/>
</authorList>
<dbReference type="PubMed" id="23112346"/>
<dbReference type="DOI" id="10.1126/scisignal.2002936"/>
</citation>
<scope>INTERACTION WITH MPIG6B</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-584</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="45">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="46">
<citation type="journal article" date="1998" name="Cell" volume="92" first="441" last="450">
<title>Crystal structure of the tyrosine phosphatase SHP-2.</title>
<authorList>
<person name="Hof P."/>
<person name="Pluskey S."/>
<person name="Dhe-Paganon S."/>
<person name="Eck M.J."/>
<person name="Shoelson S.E."/>
</authorList>
<dbReference type="PubMed" id="9491886"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)80938-1"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 3-530 (ISOFORM 2)</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2009" name="Cell" volume="136" first="352" last="363">
<title>Large-scale structural analysis of the classical human protein tyrosine phosphatome.</title>
<authorList>
<person name="Barr A.J."/>
<person name="Ugochukwu E."/>
<person name="Lee W.H."/>
<person name="King O.N.F."/>
<person name="Filippakopoulos P."/>
<person name="Alfano I."/>
<person name="Savitsky P."/>
<person name="Burgess-Brown N.A."/>
<person name="Mueller S."/>
<person name="Knapp S."/>
</authorList>
<dbReference type="PubMed" id="19167335"/>
<dbReference type="DOI" id="10.1016/j.cell.2008.11.038"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 237-533</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2010" name="J. Med. Chem." volume="53" first="2482" last="2493">
<title>Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2).</title>
<authorList>
<person name="Zhang X."/>
<person name="He Y."/>
<person name="Liu S."/>
<person name="Yu Z."/>
<person name="Jiang Z.X."/>
<person name="Yang Z."/>
<person name="Dong Y."/>
<person name="Nabinger S.C."/>
<person name="Wu L."/>
<person name="Gunawan A.M."/>
<person name="Wang L."/>
<person name="Chan R.J."/>
<person name="Zhang Z.Y."/>
</authorList>
<dbReference type="PubMed" id="20170098"/>
<dbReference type="DOI" id="10.1021/jm901645u"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 262-532 IN COMPLEX WITH INHIBITOR</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2001" name="Nat. Genet." volume="29" first="465" last="468">
<title>Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome.</title>
<authorList>
<person name="Tartaglia M."/>
<person name="Mehler E.L."/>
<person name="Goldberg R."/>
<person name="Zampino G."/>
<person name="Brunner H.G."/>
<person name="Kremer H."/>
<person name="van der Burgt I."/>
<person name="Crosby A.H."/>
<person name="Ion A."/>
<person name="Jeffery S."/>
<person name="Kalidas K."/>
<person name="Patton M.A."/>
<person name="Kucherlapati R.S."/>
<person name="Gelb B.D."/>
</authorList>
<dbReference type="PubMed" id="11704759"/>
<dbReference type="DOI" id="10.1038/ng772"/>
</citation>
<scope>VARIANTS NS1 GLY-61; CYS-63; GLY-72; SER-72; ASP-76; ARG-79; VAL-282; ASP-308 AND VAL-508</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2001" name="Nat. Genet." volume="29" first="491" last="491">
<authorList>
<person name="Tartaglia M."/>
<person name="Mehler E.L."/>
<person name="Goldberg R."/>
<person name="Zampino G."/>
<person name="Brunner H.G."/>
<person name="Kremer H."/>
<person name="van der Burgt I."/>
<person name="Crosby A.H."/>
<person name="Ion A."/>
<person name="Jeffery S."/>
<person name="Kalidas K."/>
<person name="Patton M.A."/>
<person name="Kucherlapati R.S."/>
<person name="Gelb B.D."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2001" name="Nat. Genet." volume="30" first="123" last="123">
<authorList>
<person name="Tartaglia M."/>
<person name="Mehler E.L."/>
<person name="Goldberg R."/>
<person name="Zampino G."/>
<person name="Brunner H.G."/>
<person name="Kremer H."/>
<person name="van der Burgt I."/>
<person name="Crosby A.H."/>
<person name="Ion A."/>
<person name="Jeffery S."/>
<person name="Kalidas K."/>
<person name="Patton M.A."/>
<person name="Kucherlapati R.S."/>
<person name="Gelb B.D."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2002" name="Am. J. Hum. Genet." volume="70" first="1555" last="1563">
<title>PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity.</title>
<authorList>
<person name="Tartaglia M."/>
<person name="Kalidas K."/>
<person name="Shaw A."/>
<person name="Song X."/>
<person name="Musat D.L."/>
<person name="van der Burgt I."/>
<person name="Brunner H.G."/>
<person name="Bertola D.R."/>
<person name="Crosby A.H."/>
<person name="Ion A."/>
<person name="Kucherlapati R.S."/>
<person name="Jeffery S."/>
<person name="Patton M.A."/>
<person name="Gelb B.D."/>
</authorList>
<dbReference type="PubMed" id="11992261"/>
<dbReference type="DOI" id="10.1086/340847"/>
</citation>
<scope>VARIANTS NS1 ALA-42; ALA-60; ASN-61; GLY-61; ASP-62; CYS-63; GLY-72; ILE-73; ASP-76; ARG-79; ALA-106; ASP-139; CYS-279; VAL-282; LEU-285; SER-285; ASP-308; SER-308; VAL-309; LYS-505 AND VAL-508</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2002" name="Am. J. Hum. Genet." volume="71" first="389" last="394">
<title>Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene.</title>
<authorList>
<person name="Digilio M.C."/>
<person name="Conti E."/>
<person name="Sarkozy A."/>
<person name="Mingarelli R."/>
<person name="Dottorini T."/>
<person name="Marino B."/>
<person name="Pizzuti A."/>
<person name="Dallapiccola B."/>
</authorList>
<dbReference type="PubMed" id="12058348"/>
<dbReference type="DOI" id="10.1086/341528"/>
</citation>
<scope>VARIANTS LPRD1 CYS-279 AND MET-472</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2002" name="Hum. Mutat." volume="20" first="298" last="304">
<title>PTPN11 mutations in Noonan syndrome type I: detection of recurrent mutations in exons 3 and 13.</title>
<authorList>
<person name="Maheshwari M."/>
<person name="Belmont J."/>
<person name="Fernbach S."/>
<person name="Ho T."/>
<person name="Molinari L."/>
<person name="Yakub I."/>
<person name="Yu F."/>
<person name="Combes A."/>
<person name="Towbin J.A."/>
<person name="Craigen W.J."/>
<person name="Gibbs R.A."/>
</authorList>
<dbReference type="PubMed" id="12325025"/>
<dbReference type="DOI" id="10.1002/humu.10129"/>
</citation>
<scope>VARIANTS NS1 ASP-62; CYS-63 AND THR-506</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2002" name="J. Clin. Endocrinol. Metab." volume="87" first="3529" last="3533">
<title>PTPN11 (protein-tyrosine phosphatase, nonreceptor-type 11) mutations in seven Japanese patients with Noonan syndrome.</title>
<authorList>
<person name="Kosaki K."/>
<person name="Suzuki T."/>
<person name="Muroya K."/>
<person name="Hasegawa T."/>
<person name="Sato S."/>
<person name="Matsuo N."/>
<person name="Kosaki R."/>
<person name="Nagai T."/>
<person name="Hasegawa Y."/>
<person name="Ogata T."/>
</authorList>
<dbReference type="PubMed" id="12161469"/>
<dbReference type="DOI" id="10.1210/jcem.87.8.8694"/>
</citation>
<scope>VARIANTS NS1 GLY-61; CYS-63; SER-72; ILE-73; SER-285 AND ASP-308</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2003" name="Eur. J. Hum. Genet." volume="11" first="85" last="88">
<title>PTPN11 mutation in a large family with Noonan syndrome and dizygous twinning.</title>
<authorList>
<person name="Schollen E."/>
<person name="Matthijs G."/>
<person name="Gewillig M."/>
<person name="Fryns J.-P."/>
<person name="Legius E."/>
</authorList>
<dbReference type="PubMed" id="12529711"/>
<dbReference type="DOI" id="10.1038/sj.ejhg.5200915"/>
</citation>
<scope>VARIANT NS1 ARG-79</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2003" name="Eur. J. Hum. Genet." volume="11" first="201" last="206">
<title>Spectrum of mutations in PTPN11 and genotype-phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome.</title>
<authorList>
<person name="Musante L."/>
<person name="Kehl H.G."/>
<person name="Majewski F."/>
<person name="Meinecke P."/>
<person name="Schweiger S."/>
<person name="Gillessen-Kaesbach G."/>
<person name="Wieczorek D."/>
<person name="Hinkel G.K."/>
<person name="Tinschert S."/>
<person name="Hoeltzenbein M."/>
<person name="Ropers H.-H."/>
<person name="Kalscheuer V.M."/>
</authorList>
<dbReference type="PubMed" id="12634870"/>
<dbReference type="DOI" id="10.1038/sj.ejhg.5200935"/>
</citation>
<scope>VARIANTS NS1 LYS-58; ASN-61; GLY-61; CYS-63; GLN-69; LEU-71; SER-72; ILE-73; ASP-76; ARG-79; ASP-139; ARG-256; VAL-282 AND ASP-308</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2003" name="Eur. J. Hum. Genet." volume="11" first="551" last="551">
<authorList>
<person name="Musante L."/>
<person name="Kehl H.G."/>
<person name="Majewski F."/>
<person name="Meinecke P."/>
<person name="Schweiger S."/>
<person name="Gillessen-Kaesbach G."/>
<person name="Wieczorek D."/>
<person name="Hinkel G.K."/>
<person name="Tinschert S."/>
<person name="Hoeltzenbein M."/>
<person name="Ropers H.-H."/>
<person name="Kalscheuer V.M."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2003" name="Eur. J. Pediatr." volume="162" first="548" last="549">
<title>Noonan syndrome with leukaemoid reaction and overproduction of catecholamines: a case report.</title>
<authorList>
<person name="Kondoh T."/>
<person name="Ishii E."/>
<person name="Aoki Y."/>
<person name="Shimizu T."/>
<person name="Zaitsu M."/>
<person name="Matsubara Y."/>
<person name="Moriuchi H."/>
</authorList>
<dbReference type="PubMed" id="12739139"/>
<dbReference type="DOI" id="10.1007/s00431-003-1227-6"/>
</citation>
<scope>VARIANT NS1 THR-506</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2003" name="Hum. Mutat." volume="21" first="654" last="654">
<title>A novel PTPN11 mutation in LEOPARD syndrome.</title>
<authorList>
<person name="Conti E."/>
<person name="Dottorini T."/>
<person name="Sarkozy A."/>
<person name="Tiller G.E."/>
<person name="Esposito G."/>
<person name="Pizzuti A."/>
<person name="Dallapiccola B."/>
</authorList>
<dbReference type="PubMed" id="14961557"/>
<dbReference type="DOI" id="10.1002/humu.9149"/>
</citation>
<scope>VARIANT LPRD1 PRO-510</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2003" name="J. Med. Genet." volume="40" first="704" last="708">
<title>Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes.</title>
<authorList>
<person name="Sarkozy A."/>
<person name="Conti E."/>
<person name="Seripa D."/>
<person name="Digilio M.C."/>
<person name="Grifone N."/>
<person name="Tandoi C."/>
<person name="Fazio V.M."/>
<person name="Di Ciommo V."/>
<person name="Marino B."/>
<person name="Pizzuti A."/>
<person name="Dallapiccola B."/>
</authorList>
<dbReference type="PubMed" id="12960218"/>
<dbReference type="DOI" id="10.1136/jmg.40.9.704"/>
</citation>
<scope>VARIANTS NS1 ILE-2; ALA-42; ASP-62; CYS-63; GLY-72; PRO-79; ALA-106; CYS-279; ASP-308; SER-308; MET-472; ARG-507; VAL-508 AND PHE-564</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2003" name="Nat. Genet." volume="34" first="148" last="150">
<title>Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia.</title>
<authorList>
<person name="Tartaglia M."/>
<person name="Niemeyer C.M."/>
<person name="Fragale A."/>
<person name="Song X."/>
<person name="Buechner J."/>
<person name="Jung A."/>
<person name="Haehlen K."/>
<person name="Hasle H."/>
<person name="Licht J.D."/>
<person name="Gelb B.D."/>
</authorList>
<dbReference type="PubMed" id="12717436"/>
<dbReference type="DOI" id="10.1038/ng1156"/>
</citation>
<scope>VARIANTS JMML TYR-61; VAL-61; LYS-69; THR-72; VAL-72; ALA-76; GLY-76; LYS-76; VAL-76; ALA-507 AND ARG-507</scope>
<scope>VARIANTS MYELODYSPLASTIC SYNDROME VAL-60; VAL-61; LYS-69; LEU-71 AND ALA-76</scope>
<scope>VARIANTS NS1 ASP-62 AND ILE-73</scope>
<scope>VARIANT ACUTE MYELOID LEUKEMIA LYS-71</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2004" name="Am. J. Med. Genet. A" volume="130" first="378" last="383">
<title>Clinical variability in a Noonan syndrome family with a new PTPN11 gene mutation.</title>
<authorList>
<person name="Bertola D.R."/>
<person name="Pereira A.C."/>
<person name="de Oliveira P.S.L."/>
<person name="Kim C.A."/>
<person name="Krieger J.E."/>
</authorList>
<dbReference type="PubMed" id="15384080"/>
<dbReference type="DOI" id="10.1002/ajmg.a.30270"/>
</citation>
<scope>VARIANT NS1 MET-415</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2004" name="Am. J. Med. Genet. A" volume="130" first="432" last="434">
<title>Two novel and one recurrent PTPN11 mutations in LEOPARD syndrome.</title>
<authorList>
<person name="Yoshida R."/>
<person name="Nagai T."/>
<person name="Hasegawa T."/>
<person name="Kinoshita E."/>
<person name="Tanaka T."/>
<person name="Ogata T."/>
</authorList>
<dbReference type="PubMed" id="15389709"/>
<dbReference type="DOI" id="10.1002/ajmg.a.30281"/>
</citation>
<scope>VARIANTS LPRD1 THR-465 AND ALA-468</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2004" name="J. Med. Genet." volume="41" first="E117" last="E117">
<title>PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience.</title>
<authorList>
<consortium name="French collaborative Noonan study group"/>
<person name="Keren B."/>
<person name="Hadchouel A."/>
<person name="Saba S."/>
<person name="Sznajer Y."/>
<person name="Bonneau D."/>
<person name="Leheup B."/>
<person name="Boute O."/>
<person name="Gaillard D."/>
<person name="Lacombe D."/>
<person name="Layet V."/>
<person name="Marlin S."/>
<person name="Mortier G."/>
<person name="Toutain A."/>
<person name="Beylot C."/>
<person name="Baumann C."/>
<person name="Verloes A."/>
<person name="Cave H."/>
</authorList>
<dbReference type="PubMed" id="15520399"/>
<dbReference type="DOI" id="10.1136/jmg.2004.021451"/>
</citation>
<scope>VARIANTS LPRD1 CYS-279; SER-279; MET-472 AND PRO-514</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2004" name="J. Med. Genet." volume="41" first="E68" last="E68">
<title>Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome.</title>
<authorList>
<person name="Sarkozy A."/>
<person name="Conti E."/>
<person name="Digilio M.C."/>
<person name="Marino B."/>
<person name="Morini E."/>
<person name="Pacileo G."/>
<person name="Wilson M."/>
<person name="Calabro R."/>
<person name="Pizzuti A."/>
<person name="Dallapiccola B."/>
</authorList>
<dbReference type="PubMed" id="15121796"/>
<dbReference type="DOI" id="10.1136/jmg.2003.013466"/>
</citation>
<scope>VARIANTS LPRD1 CYS-279; SER-279; ALA-468; MET-472; TRP-502; LEU-502 AND PRO-510</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2005" name="Am. J. Med. Genet. A" volume="136" first="242" last="245">
<title>Neurofibromatosis-Noonan syndrome: molecular evidence of the concurrence of both disorders in a patient.</title>
<authorList>
<person name="Bertola D.R."/>
<person name="Pereira A.C."/>
<person name="Passetti F."/>
<person name="de Oliveira P.S.L."/>
<person name="Messiaen L."/>
<person name="Gelb B.D."/>
<person name="Kim C.A."/>
<person name="Krieger J.E."/>
</authorList>
<dbReference type="PubMed" id="15948193"/>
<dbReference type="DOI" id="10.1002/ajmg.a.30813"/>
</citation>
<scope>VARIANT NS1 ARG-510</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2005" name="Eur. J. Pediatr." volume="164" first="497" last="500">
<title>A novel mutation in the PTPN11 gene in a patient with Noonan syndrome and rapidly progressive hypertrophic cardiomyopathy.</title>
<authorList>
<person name="Takahashi K."/>
<person name="Kogaki S."/>
<person name="Kurotobi S."/>
<person name="Nasuno S."/>
<person name="Ohta M."/>
<person name="Okabe H."/>
<person name="Wada K."/>
<person name="Sakai N."/>
<person name="Taniike M."/>
<person name="Ozono K."/>
</authorList>
<dbReference type="PubMed" id="15889278"/>
<dbReference type="DOI" id="10.1007/s00431-005-1679-y"/>
</citation>
<scope>VARIANT NS1 GLU-514</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2005" name="J. Hum. Genet." volume="50" first="21" last="25">
<title>Genetic heterogeneity in LEOPARD syndrome: two families with no mutations in PTPN11.</title>
<authorList>
<person name="Kalidas K."/>
<person name="Shaw A.C."/>
<person name="Crosby A.H."/>
<person name="Newbury-Ecob R."/>
<person name="Greenhalgh L."/>
<person name="Temple I.K."/>
<person name="Law C."/>
<person name="Patel A."/>
<person name="Patton M.A."/>
<person name="Jeffery S."/>
</authorList>
<dbReference type="PubMed" id="15690106"/>
<dbReference type="DOI" id="10.1007/s10038-004-0212-x"/>
</citation>
<scope>VARIANT LPRD1 PRO-510</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2006" name="Eur. J. Pediatr." volume="165" first="803" last="805">
<title>PTPN11 gene mutations: linking the Gln510Glu mutation to the 'LEOPARD syndrome phenotype'.</title>
<authorList>
<person name="Digilio M.C."/>
<person name="Sarkozy A."/>
<person name="Pacileo G."/>
<person name="Limongelli G."/>
<person name="Marino B."/>
<person name="Dallapiccola B."/>
</authorList>
<dbReference type="PubMed" id="16733669"/>
<dbReference type="DOI" id="10.1007/s00431-006-0163-7"/>
</citation>
<scope>VARIANT LPRD1 GLU-514</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2006" name="J. Pediatr. Hematol. Oncol." volume="28" first="123" last="125">
<title>Acute myelomonocytic leukemia in a boy with LEOPARD syndrome (PTPN11 gene mutation positive).</title>
<authorList>
<person name="Ucar C."/>
<person name="Calyskan U."/>
<person name="Martini S."/>
<person name="Heinritz W."/>
</authorList>
<dbReference type="PubMed" id="16679933"/>
<dbReference type="DOI" id="10.1097/01.mph.0000199590.21797.0b"/>
</citation>
<scope>VARIANT LPRD1 CYS-279</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2008" name="J. Hum. Genet." volume="53" first="999" last="1006">
<title>PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype-phenotype correlation in Korean patients with Noonan syndrome.</title>
<authorList>
<person name="Ko J.M."/>
<person name="Kim J.M."/>
<person name="Kim G.H."/>
<person name="Yoo H.W."/>
</authorList>
<dbReference type="PubMed" id="19020799"/>
<dbReference type="DOI" id="10.1007/s10038-008-0343-6"/>
</citation>
<scope>VARIANT NS1 ALA-59</scope>
</reference>
<reference key="73">
<citation type="journal article" date="2014" name="Am. J. Med. Genet. A" volume="164" first="2351" last="2355">
<title>A PTPN11 allele encoding a catalytically impaired SHP2 protein in a patient with a Noonan syndrome phenotype.</title>
<authorList>
<person name="Edwards J.J."/>
<person name="Martinelli S."/>
<person name="Pannone L."/>
<person name="Lo I.F."/>
<person name="Shi L."/>
<person name="Edelmann L."/>
<person name="Tartaglia M."/>
<person name="Luk H.M."/>
<person name="Gelb B.D."/>
</authorList>
<dbReference type="PubMed" id="24891296"/>
<dbReference type="DOI" id="10.1002/ajmg.a.36620"/>
</citation>
<scope>VARIANT NS1 SER-495</scope>
<scope>VARIANT LPRD1 TRP-502</scope>
<scope>CHARACTERIZATION OF VARIANTS NS1 SER-495</scope>
<scope>CHARACTERIZATION OF VARIANT LPRD1 TRP-502</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2016" name="Biochem. Biophys. Res. Commun." volume="469" first="1133" last="1139">
<title>Determination of the catalytic activity of LEOPARD syndrome-associated SHP2 mutants toward parafibromin, a bona fide SHP2 substrate involved in Wnt signaling.</title>
<authorList>
<person name="Noda S."/>
<person name="Takahashi A."/>
<person name="Hayashi T."/>
<person name="Tanuma S."/>
<person name="Hatakeyama M."/>
</authorList>
<dbReference type="PubMed" id="26742426"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2015.12.117"/>
</citation>
<scope>VARIANT JMML LYS-76</scope>
<scope>CHARACTERIZATION OF VARIANT JMML LYS-76</scope>
<scope>VARIANTS LPRD1 CYS-279; MET-472; PRO-510 AND GLU-514</scope>
<scope>CHARACTERIZATION OF VARIANTS LPRD1 CYS-279; MET-472; PRO-510 AND GLU-514</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH CDC73</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2017" name="Hum. Mutat." volume="38" first="451" last="459">
<title>Structural, Functional, and Clinical Characterization of a Novel PTPN11 Mutation Cluster Underlying Noonan Syndrome.</title>
<authorList>
<person name="Pannone L."/>
<person name="Bocchinfuso G."/>
<person name="Flex E."/>
<person name="Rossi C."/>
<person name="Baldassarre G."/>
<person name="Lissewski C."/>
<person name="Pantaleoni F."/>
<person name="Consoli F."/>
<person name="Lepri F."/>
<person name="Magliozzi M."/>
<person name="Anselmi M."/>
<person name="Delle Vigne S."/>
<person name="Sorge G."/>
<person name="Karaer K."/>
<person name="Cuturilo G."/>
<person name="Sartorio A."/>
<person name="Tinschert S."/>
<person name="Accadia M."/>
<person name="Digilio M.C."/>
<person name="Zampino G."/>
<person name="De Luca A."/>
<person name="Cav e H."/>
<person name="Zenker M."/>
<person name="Gelb B.D."/>
<person name="Dallapiccola B."/>
<person name="Stella L."/>
<person name="Ferrero G.B."/>
<person name="Martinelli S."/>
<person name="Tartaglia M."/>
</authorList>
<dbReference type="PubMed" id="28074573"/>
<dbReference type="DOI" id="10.1002/humu.23175"/>
</citation>
<scope>VARIANTS NS1 HIS-261; PHE-261; ARG-262; PHE-262 AND GLN-265</scope>
<scope>CHARACTERIZATION VARIANTS NS1 HIS-261; PHE-261; ARG-262; PHE-262 AND GLN-265</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<comment type="function">
<text evidence="29 62 64 74 75">Acts downstream of various receptor and cytoplasmic protein tyrosine kinases to participate in the signal transduction from the cell surface to the nucleus. Positively regulates MAPK signal transduction pathway (PubMed:28074573). Dephosphorylates GAB1, ARHGAP35 and EGFR (PubMed:28074573). Dephosphorylates ROCK2 at 'Tyr-722' resulting in stimulatation of its RhoA binding activity. Dephosphorylates CDC73 (PubMed:26742426).</text>
</comment>
<comment type="catalytic activity">
<text evidence="26 69 74 75">Protein tyrosine phosphate + H(2)O = protein tyrosine + phosphate.</text>
</comment>
<comment type="subunit">
<text evidence="22 23 27 28 29 30 31 32 33 34 46 47 49 59 60 61 63 64 66 67 68 69 70 72 74 78 81 82 83">Interacts with phosphorylated LIME1 and BCAR3. Interacts with SHB and INPP5D/SHIP1 (By similarity). Interacts with MILR1 (tyrosine-phosphorylated). Interacts with FLT1 (tyrosine-phosphorylated), FLT3 (tyrosine-phosphorylated), FLT4 (tyrosine-phosphorylated), KIT and GRB2. Interacts with PDGFRA (tyrosine phosphorylated). Interacts (via SH2 domain) with TEK/TIE2 (tyrosine phosphorylated) (By similarity). Interacts with PTPNS1 and CD84. Interacts with phosphorylated SIT1 and MPZL1. Interacts with FCRL4, FCRL6 and ANKHD1. Interacts with KIR2DL1; the interaction is enhanced by ARRB2. Interacts with GAB2. Interacts with TERT; the interaction retains TERT in the nucleus. Interacts with PECAM1 and FER. Interacts with EPHA2 (activated); participates in PTK2/FAK1 dephosphorylation in EPHA2 downstream signaling. Interacts with ROS1; mediates PTPN11 phosphorylation. Interacts with PDGFRB (tyrosine phosphorylated); this interaction increases the PTPN11 phosphatase activity. Interacts with GAREM1 isoform 1 (tyrosine phosphorylated); the interaction increases MAPK/ERK activity and does not affect the GRB2/SOS complex formation. Interacts with CDC73 (PubMed:26742426). Interacts with CEACAM1 (via cytoplasmic domain); this interaction depends on the monomer/dimer equilibrium and is phosphorylation-dependent (By similarity). Interacts with MPIG6B (via ITIM motif) (PubMed:23112346). Interacts with SIGLEC10 (By similarity). Interacts with FCRL3 (via phosphorylated ITIM motifs) (PubMed:11162587, PubMed:19843936).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-608057">
<id>P10275</id>
<label>AR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-1753137">
<id>P32239</id>
<label>CCKBR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-1580565">
<id>Q9BZW8</id>
<label>CD244</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-3906571">
<id>P20138</id>
<label>CD33</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-711879">
<id>Q08345</id>
<label>DDR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-7645934">
<id>P68105</id>
<label>EEF1A1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-7645815">
<id>Q71V39</id>
<label>EEF1A2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-641062">
<id>P04626</id>
<label>ERBB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-1026718">
<id>P17948</id>
<label>FLT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-517684">
<id>Q13480</id>
<label>GAB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>39</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-975200">
<id>Q9UQC2</id>
<label>GAB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-371669">
<id>O75496</id>
<label>GMNN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-475981">
<id>P08069</id>
<label>IGF1R</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-475899">
<id>P06213</id>
<label>INSR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-517592">
<id>P35568</id>
<label>IRS1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-520230">
<id>P35570</id>
<label>Irs1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-8632435">
<id>P43628</id>
<label>KIR2DL3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-1379503">
<id>P10721</id>
<label>KIT</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>29</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-1039152">
<id>P08581</id>
<label>MET</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-963338">
<id>O95297</id>
<label>MPZL1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-4314328">
<id>Q15116</id>
<label>PDCD1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-641237">
<id>P09619</id>
<label>PDGFRB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-716404">
<id>P16284</id>
<label>PECAM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-702209">
<id>P49023</id>
<label>PXN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-744831">
<id>P49247</id>
<label>RPIA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-7945080">
<id>P97710</id>
<label>Sirpa</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-297779"/>
<interactant intactId="EBI-742790">
<id>Q13049</id>
<label>TRIM32</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="74">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="74">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q06124-1</id>
<name>1</name>
<name>PTP2Ci</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q06124-2</id>
<name>2</name>
<name>PTP2C</name>
<sequence type="described" ref="VSP_016672"/>
</isoform>
<isoform>
<id>Q06124-3</id>
<name>3</name>
<sequence type="described" ref="VSP_016672 VSP_016673 VSP_016674"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="44 77 80">Widely expressed, with highest levels in heart, brain, and skeletal muscle.</text>
</comment>
<comment type="domain">
<text>The SH2 domains repress phosphatase activity. Binding of these domains to phosphotyrosine-containing proteins relieves this auto-inhibition, possibly by inducing a conformational change in the enzyme.</text>
</comment>
<comment type="PTM">
<text evidence="21 70 76 78 79">Phosphorylated on Tyr-546 and Tyr-584 upon receptor protein tyrosine kinase activation; which creates a binding site for GRB2 and other SH2-containing proteins. Phosphorylated upon activation of the receptor-type kinase FLT3. Phosphorylated upon activation of the receptor-type kinase PDGFRA (By similarity). Phosphorylated by activated PDGFRB.</text>
</comment>
<comment type="disease" evidence="37 48 50 52 53 54 57 58 73 74">
<disease id="DI-01888">
<name>LEOPARD syndrome 1</name>
<acronym>LPRD1</acronym>
<description>A disorder characterized by lentigines, electrocardiographic conduction abnormalities, ocular hypertelorism, pulmonic stenosis, abnormalities of genitalia, retardation of growth, and sensorineural deafness.</description>
<dbReference type="MIM" id="151100"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="35 36 38 39 40 41 42 43 45 51 55 56 65 73 75">
<disease id="DI-02072">
<name>Noonan syndrome 1</name>
<acronym>NS1</acronym>
<description>A form of Noonan syndrome, a disease characterized by short stature, facial dysmorphic features such as hypertelorism, a downward eyeslant and low-set posteriorly rotated ears, and a high incidence of congenital heart defects and hypertrophic cardiomyopathy. Other features can include a short neck with webbing or redundancy of skin, deafness, motor delay, variable intellectual deficits, multiple skeletal defects, cryptorchidism, and bleeding diathesis. Individuals with Noonan syndrome are at risk of juvenile myelomonocytic leukemia, a myeloproliferative disorder characterized by excessive production of myelomonocytic cells. Some patients with NS1 develop multiple giant cell lesions of the jaw or other bony or soft tissues, which are classified as pigmented villonodular synovitis (PVNS) when occurring in the jaw or joints.</description>
<dbReference type="MIM" id="163950"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry. Mutations in PTPN11 account for more than 50% of the cases.</text>
</comment>
<comment type="disease" evidence="42 74">
<disease id="DI-01851">
<name>Leukemia, juvenile myelomonocytic</name>
<acronym>JMML</acronym>
<description>An aggressive pediatric myelodysplastic syndrome/myeloproliferative disorder characterized by malignant transformation in the hematopoietic stem cell compartment with proliferation of differentiated progeny. Patients have splenomegaly, enlarged lymph nodes, rashes, and hemorrhages.</description>
<dbReference type="MIM" id="607785"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="71">
<disease id="DI-02832">
<name>Metachondromatosis</name>
<acronym>MC</acronym>
<description>A skeletal disorder with radiologic features of both multiple exostoses and Ollier disease, characterized by the presence of exostoses, commonly of the bones of the hands and feet, and enchondromas of the metaphyses of long bones and iliac crest.</description>
<dbReference type="MIM" id="156250"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="91">Belongs to the protein-tyrosine phosphatase family. Non-receptor class 2 subfamily.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/PTPN11ID41910ch12q24.html"/>
</comment>
<dbReference type="EC" id="3.1.3.48" evidence="74 75"/>
<dbReference type="EMBL" id="D13540">
<property type="protein sequence ID" value="BAA02740.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L03535">
<property type="protein sequence ID" value="AAA36611.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L07527">
<property type="protein sequence ID" value="AAA17022.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L08807">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="X70766">
<property type="protein sequence ID" value="CAA50045.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT007106">
<property type="protein sequence ID" value="AAP35770.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK289854">
<property type="protein sequence ID" value="BAF82543.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471054">
<property type="protein sequence ID" value="EAW98012.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC008692">
<property type="protein sequence ID" value="AAH08692.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS58280.1">
<molecule id="Q06124-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS81741.1">
<molecule id="Q06124-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS9163.1">
<molecule id="Q06124-2"/>
</dbReference>
<dbReference type="PIR" id="JN0805">
<property type="entry name" value="JN0805"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001317366.1">
<molecule id="Q06124-1"/>
<property type="nucleotide sequence ID" value="NM_001330437.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002825.3">
<molecule id="Q06124-2"/>
<property type="nucleotide sequence ID" value="NM_002834.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_542168.1">
<molecule id="Q06124-3"/>
<property type="nucleotide sequence ID" value="NM_080601.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.506852"/>
<dbReference type="PDB" id="2SHP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=1-529"/>
</dbReference>
<dbReference type="PDB" id="3B7O">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=237-533"/>
</dbReference>
<dbReference type="PDB" id="3MOW">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=262-532"/>
</dbReference>
<dbReference type="PDB" id="3O5X">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=262-532"/>
</dbReference>
<dbReference type="PDB" id="3TKZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=1-106"/>
</dbReference>
<dbReference type="PDB" id="3TL0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A=1-106"/>
</dbReference>
<dbReference type="PDB" id="3ZM0">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=248-531"/>
</dbReference>
<dbReference type="PDB" id="3ZM1">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="A=248-531"/>
</dbReference>
<dbReference type="PDB" id="3ZM2">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=248-531"/>
</dbReference>
<dbReference type="PDB" id="3ZM3">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=248-531"/>
</dbReference>
<dbReference type="PDB" id="4DGP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=1-532"/>
</dbReference>
<dbReference type="PDB" id="4DGX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=1-532"/>
</dbReference>
<dbReference type="PDB" id="4GWF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=1-543"/>
</dbReference>
<dbReference type="PDB" id="4H1O">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=1-543"/>
</dbReference>
<dbReference type="PDB" id="4H34">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=1-543"/>
</dbReference>
<dbReference type="PDB" id="4JE4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.31"/>
<property type="chains" value="A=1-103"/>
</dbReference>
<dbReference type="PDB" id="4JEG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=97-217"/>
</dbReference>
<dbReference type="PDB" id="4JMG">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.40"/>
<property type="chains" value="B=579-591"/>
</dbReference>
<dbReference type="PDB" id="4NWF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=1-543"/>
</dbReference>
<dbReference type="PDB" id="4NWG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="A/B=1-543"/>
</dbReference>
<dbReference type="PDB" id="4OHD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=1-532"/>
</dbReference>
<dbReference type="PDB" id="4OHE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.51"/>
<property type="chains" value="A=1-532"/>
</dbReference>
<dbReference type="PDB" id="4OHH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.70"/>
<property type="chains" value="A=1-532"/>
</dbReference>
<dbReference type="PDB" id="4OHI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=1-532"/>
</dbReference>
<dbReference type="PDB" id="4OHL">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=1-532"/>
</dbReference>
<dbReference type="PDB" id="4PVG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=240-532"/>
</dbReference>
<dbReference type="PDB" id="4QSY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=1-106"/>
</dbReference>
<dbReference type="PDB" id="4RDD">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=262-532"/>
</dbReference>
<dbReference type="PDB" id="5DF6">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.78"/>
<property type="chains" value="A=1-222"/>
</dbReference>
<dbReference type="PDB" id="5EHP">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A/B=1-529"/>
</dbReference>
<dbReference type="PDB" id="5EHR">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A/B=1-529"/>
</dbReference>
<dbReference type="PDB" id="5I6V">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.87"/>
<property type="chains" value="A/B=1-529"/>
</dbReference>
<dbReference type="PDB" id="5IBM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.18"/>
<property type="chains" value="A/B=1-529"/>
</dbReference>
<dbReference type="PDB" id="5IBS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.32"/>
<property type="chains" value="A/B=1-529"/>
</dbReference>
<dbReference type="PDB" id="5X7B">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="A=1-220"/>
</dbReference>
<dbReference type="PDB" id="5X94">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=1-220"/>
</dbReference>
<dbReference type="PDBsum" id="2SHP"/>
<dbReference type="PDBsum" id="3B7O"/>
<dbReference type="PDBsum" id="3MOW"/>
<dbReference type="PDBsum" id="3O5X"/>
<dbReference type="PDBsum" id="3TKZ"/>
<dbReference type="PDBsum" id="3TL0"/>
<dbReference type="PDBsum" id="3ZM0"/>
<dbReference type="PDBsum" id="3ZM1"/>
<dbReference type="PDBsum" id="3ZM2"/>
<dbReference type="PDBsum" id="3ZM3"/>
<dbReference type="PDBsum" id="4DGP"/>
<dbReference type="PDBsum" id="4DGX"/>
<dbReference type="PDBsum" id="4GWF"/>
<dbReference type="PDBsum" id="4H1O"/>
<dbReference type="PDBsum" id="4H34"/>
<dbReference type="PDBsum" id="4JE4"/>
<dbReference type="PDBsum" id="4JEG"/>
<dbReference type="PDBsum" id="4JMG"/>
<dbReference type="PDBsum" id="4NWF"/>
<dbReference type="PDBsum" id="4NWG"/>
<dbReference type="PDBsum" id="4OHD"/>
<dbReference type="PDBsum" id="4OHE"/>
<dbReference type="PDBsum" id="4OHH"/>
<dbReference type="PDBsum" id="4OHI"/>
<dbReference type="PDBsum" id="4OHL"/>
<dbReference type="PDBsum" id="4PVG"/>
<dbReference type="PDBsum" id="4QSY"/>
<dbReference type="PDBsum" id="4RDD"/>
<dbReference type="PDBsum" id="5DF6"/>
<dbReference type="PDBsum" id="5EHP"/>
<dbReference type="PDBsum" id="5EHR"/>
<dbReference type="PDBsum" id="5I6V"/>
<dbReference type="PDBsum" id="5IBM"/>
<dbReference type="PDBsum" id="5IBS"/>
<dbReference type="PDBsum" id="5X7B"/>
<dbReference type="PDBsum" id="5X94"/>
<dbReference type="ProteinModelPortal" id="Q06124"/>
<dbReference type="SMR" id="Q06124"/>
<dbReference type="BioGrid" id="111745">
<property type="interactions" value="141"/>
</dbReference>
<dbReference type="CORUM" id="Q06124"/>
<dbReference type="DIP" id="DIP-516N"/>
<dbReference type="ELM" id="Q06124"/>
<dbReference type="IntAct" id="Q06124">
<property type="interactions" value="72"/>
</dbReference>
<dbReference type="MINT" id="MINT-199832"/>
<dbReference type="STRING" id="9606.ENSP00000340944"/>
<dbReference type="BindingDB" id="Q06124"/>
<dbReference type="ChEMBL" id="CHEMBL3864"/>
<dbReference type="DrugBank" id="DB02779">
<property type="generic name" value="Dodecane-Trimethylamine"/>
</dbReference>
<dbReference type="DEPOD" id="Q06124"/>
<dbReference type="iPTMnet" id="Q06124"/>
<dbReference type="PhosphoSitePlus" id="Q06124"/>
<dbReference type="BioMuta" id="PTPN11"/>
<dbReference type="DMDM" id="84028248"/>
<dbReference type="EPD" id="Q06124"/>
<dbReference type="MaxQB" id="Q06124"/>
<dbReference type="PaxDb" id="Q06124"/>
<dbReference type="PeptideAtlas" id="Q06124"/>
<dbReference type="PRIDE" id="Q06124"/>
<dbReference type="TopDownProteomics" id="Q06124-2">
<molecule id="Q06124-2"/>
</dbReference>
<dbReference type="DNASU" id="5781"/>
<dbReference type="Ensembl" id="ENST00000351677">
<molecule id="Q06124-2"/>
<property type="protein sequence ID" value="ENSP00000340944"/>
<property type="gene ID" value="ENSG00000179295"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000392597">
<molecule id="Q06124-3"/>
<property type="protein sequence ID" value="ENSP00000376376"/>
<property type="gene ID" value="ENSG00000179295"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000635625">
<molecule id="Q06124-1"/>
<property type="protein sequence ID" value="ENSP00000489597"/>
<property type="gene ID" value="ENSG00000179295"/>
</dbReference>
<dbReference type="GeneID" id="5781"/>
<dbReference type="KEGG" id="hsa:5781"/>
<dbReference type="UCSC" id="uc001ttw.2">
<molecule id="Q06124-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5781"/>
<dbReference type="DisGeNET" id="5781"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000179295.16"/>
<dbReference type="GeneCards" id="PTPN11"/>
<dbReference type="GeneReviews" id="PTPN11"/>
<dbReference type="HGNC" id="HGNC:9644">
<property type="gene designation" value="PTPN11"/>
</dbReference>
<dbReference type="HPA" id="CAB005377"/>
<dbReference type="MalaCards" id="PTPN11"/>
<dbReference type="MIM" id="151100">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="156250">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="163950">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="176876">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="607785">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q06124"/>
<dbReference type="OpenTargets" id="ENSG00000179295"/>
<dbReference type="Orphanet" id="86834">
<property type="disease" value="Juvenile myelomonocytic leukemia"/>
</dbReference>
<dbReference type="Orphanet" id="500">
<property type="disease" value="LEOPARD syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="2499">
<property type="disease" value="Metachondromatosis"/>
</dbReference>
<dbReference type="Orphanet" id="648">
<property type="disease" value="Noonan syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA33986"/>
<dbReference type="eggNOG" id="KOG0790">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG5599">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00900000140780"/>
<dbReference type="HOGENOM" id="HOG000273907"/>
<dbReference type="HOVERGEN" id="HBG000223"/>
<dbReference type="InParanoid" id="Q06124"/>
<dbReference type="KO" id="K07293"/>
<dbReference type="OMA" id="KEYGAMR"/>
<dbReference type="OrthoDB" id="EOG091G0VZ3"/>
<dbReference type="PhylomeDB" id="Q06124"/>
<dbReference type="TreeFam" id="TF351632"/>
<dbReference type="BRENDA" id="3.1.3.48">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-109704">
<property type="pathway name" value="PI3K Cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-110056">
<property type="pathway name" value="MAPK3 (ERK1) activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-112411">
<property type="pathway name" value="MAPK1 (ERK2) activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-114604">
<property type="pathway name" value="GPVI-mediated activation cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1170546">
<property type="pathway name" value="Prolactin receptor signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1295596">
<property type="pathway name" value="Spry regulation of FGF signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1433557">
<property type="pathway name" value="Signaling by SCF-KIT"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-180292">
<property type="pathway name" value="GAB1 signalosome"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-186763">
<property type="pathway name" value="Downstream signal transduction"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-210990">
<property type="pathway name" value="PECAM1 interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-210993">
<property type="pathway name" value="Tie2 Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2219530">
<property type="pathway name" value="Constitutive Signaling by Aberrant PI3K in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2586552">
<property type="pathway name" value="Signaling by Leptin"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-388841">
<property type="pathway name" value="Costimulation by the CD28 family"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-389513">
<property type="pathway name" value="CTLA4 inhibitory signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-389948">
<property type="pathway name" value="PD-1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-391160">
<property type="pathway name" value="Signal regulatory protein family interactions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-418886">
<property type="pathway name" value="Netrin mediated repulsion signals"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-432142">
<property type="pathway name" value="Platelet sensitization by LDL"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-512988">
<property type="pathway name" value="Interleukin-3, 5 and GM-CSF signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654689">
<property type="pathway name" value="PI-3K cascade:FGFR1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654693">
<property type="pathway name" value="FRS-mediated FGFR1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654695">
<property type="pathway name" value="PI-3K cascade:FGFR2"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654700">
<property type="pathway name" value="FRS-mediated FGFR2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654706">
<property type="pathway name" value="FRS-mediated FGFR3 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654710">
<property type="pathway name" value="PI-3K cascade:FGFR3"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654712">
<property type="pathway name" value="FRS-mediated FGFR4 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654720">
<property type="pathway name" value="PI-3K cascade:FGFR4"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654726">
<property type="pathway name" value="Negative regulation of FGFR1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654727">
<property type="pathway name" value="Negative regulation of FGFR2 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654732">
<property type="pathway name" value="Negative regulation of FGFR3 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5654733">
<property type="pathway name" value="Negative regulation of FGFR4 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6783589">
<property type="pathway name" value="Interleukin-6 family signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-877312">
<property type="pathway name" value="Regulation of IFNG signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8853659">
<property type="pathway name" value="RET signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8865999">
<property type="pathway name" value="MET activates PTPN11"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8934593">
<property type="pathway name" value="Regulation of RUNX1 Expression and Activity"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-909733">
<property type="pathway name" value="Interferon alpha/beta signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-912694">
<property type="pathway name" value="Regulation of IFNA signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-936964">
<property type="pathway name" value="Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon"/>
</dbReference>
<dbReference type="SignaLink" id="Q06124"/>
<dbReference type="SIGNOR" id="Q06124"/>
<dbReference type="ChiTaRS" id="PTPN11">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q06124"/>
<dbReference type="GeneWiki" id="PTPN11"/>
<dbReference type="GenomeRNAi" id="5781"/>
<dbReference type="PRO" id="PR:Q06124"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 12"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000179295"/>
<dbReference type="CleanEx" id="HS_PTPN11"/>
<dbReference type="ExpressionAtlas" id="Q06124">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q06124">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016303">
<property type="term" value="F:1-phosphatidylinositol-3-kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0050839">
<property type="term" value="F:cell adhesion molecule binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031748">
<property type="term" value="F:D1 dopamine receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005158">
<property type="term" value="F:insulin receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043560">
<property type="term" value="F:insulin receptor substrate binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004726">
<property type="term" value="F:non-membrane spanning protein tyrosine phosphatase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051428">
<property type="term" value="F:peptide hormone receptor binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046934">
<property type="term" value="F:phosphatidylinositol-4,5-bisphosphate 3-kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043274">
<property type="term" value="F:phospholipase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004721">
<property type="term" value="F:phosphoprotein phosphatase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019904">
<property type="term" value="F:protein domain specific binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004725">
<property type="term" value="F:protein tyrosine phosphatase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030971">
<property type="term" value="F:receptor tyrosine kinase binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005070">
<property type="term" value="F:SH3/SH2 adaptor activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0033277">
<property type="term" value="P:abortive mitotic cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000187">
<property type="term" value="P:activation of MAPK activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0036302">
<property type="term" value="P:atrioventricular canal development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007411">
<property type="term" value="P:axon guidance"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0060020">
<property type="term" value="P:Bergmann glial cell differentiation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007420">
<property type="term" value="P:brain development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071364">
<property type="term" value="P:cellular response to epidermal growth factor stimulus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071260">
<property type="term" value="P:cellular response to mechanical stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0021697">
<property type="term" value="P:cerebellar cortex formation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000077">
<property type="term" value="P:DNA damage checkpoint"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048013">
<property type="term" value="P:ephrin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007173">
<property type="term" value="P:epidermal growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0038127">
<property type="term" value="P:ERBB signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060325">
<property type="term" value="P:face morphogenesis"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008543">
<property type="term" value="P:fibroblast growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048806">
<property type="term" value="P:genitalia development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042593">
<property type="term" value="P:glucose homeostasis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007507">
<property type="term" value="P:heart development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048873">
<property type="term" value="P:homeostasis of number of cells within a tissue"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042445">
<property type="term" value="P:hormone metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0009755">
<property type="term" value="P:hormone-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048839">
<property type="term" value="P:inner ear development"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007229">
<property type="term" value="P:integrin-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0061582">
<property type="term" value="P:intestinal epithelial cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050900">
<property type="term" value="P:leukocyte migration"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035855">
<property type="term" value="P:megakaryocyte development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032528">
<property type="term" value="P:microvillus organization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035264">
<property type="term" value="P:multicellular organism growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048609">
<property type="term" value="P:multicellular organismal reproductive process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033629">
<property type="term" value="P:negative regulation of cell adhesion mediated by integrin"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051463">
<property type="term" value="P:negative regulation of cortisol secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060125">
<property type="term" value="P:negative regulation of growth hormone secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046676">
<property type="term" value="P:negative regulation of insulin secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048011">
<property type="term" value="P:neurotrophin TRK receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035265">
<property type="term" value="P:organ growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035335">
<property type="term" value="P:peptidyl-tyrosine dephosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030168">
<property type="term" value="P:platelet activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030220">
<property type="term" value="P:platelet formation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048008">
<property type="term" value="P:platelet-derived growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001275">
<property type="term" value="P:positive regulation of glucose import in response to insulin stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046887">
<property type="term" value="P:positive regulation of hormone secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045931">
<property type="term" value="P:positive regulation of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051897">
<property type="term" value="P:positive regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0033628">
<property type="term" value="P:regulation of cell adhesion mediated by integrin"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0040014">
<property type="term" value="P:regulation of multicellular organism growth"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043254">
<property type="term" value="P:regulation of protein complex assembly"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046825">
<property type="term" value="P:regulation of protein export from nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060338">
<property type="term" value="P:regulation of type I interferon-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0031295">
<property type="term" value="P:T cell costimulation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006641">
<property type="term" value="P:triglyceride metabolic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.505.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Gene3D" id="3.90.190.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR029021">
<property type="entry name" value="Prot-tyrosine_phosphatase-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR000242">
<property type="entry name" value="PTPase_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR000980">
<property type="entry name" value="SH2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036860">
<property type="entry name" value="SH2_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR016130">
<property type="entry name" value="Tyr_Pase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR003595">
<property type="entry name" value="Tyr_Pase_cat"/>
</dbReference>
<dbReference type="InterPro" id="IPR012152">
<property type="entry name" value="Tyr_Pase_non-rcpt_typ-6/11"/>
</dbReference>
<dbReference type="InterPro" id="IPR000387">
<property type="entry name" value="TYR_PHOSPHATASE_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF00017">
<property type="entry name" value="SH2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF00102">
<property type="entry name" value="Y_phosphatase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000929">
<property type="entry name" value="Tyr-Ptase_nr_6"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00700">
<property type="entry name" value="PRTYPHPHTASE"/>
</dbReference>
<dbReference type="PRINTS" id="PR00401">
<property type="entry name" value="SH2DOMAIN"/>
</dbReference>
<dbReference type="SMART" id="SM00194">
<property type="entry name" value="PTPc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00404">
<property type="entry name" value="PTPc_motif"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00252">
<property type="entry name" value="SH2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52799">
<property type="entry name" value="SSF52799"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55550">
<property type="entry name" value="SSF55550"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS50001">
<property type="entry name" value="SH2"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00383">
<property type="entry name" value="TYR_PHOSPHATASE_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50056">
<property type="entry name" value="TYR_PHOSPHATASE_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50055">
<property type="entry name" value="TYR_PHOSPHATASE_PTP"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0209">Deafness</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0904">Protein phosphatase</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0727">SH2 domain</keyword>
<feature type="initiator methionine" description="Removed" evidence="18">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Tyrosine-protein phosphatase non-receptor type 11" id="PRO_0000094767">
<location>
<begin position="2"/>
<end position="597"/>
</location>
</feature>
<feature type="domain" description="SH2 1" evidence="25">
<location>
<begin position="6"/>
<end position="102"/>
</location>
</feature>
<feature type="domain" description="SH2 2" evidence="25">
<location>
<begin position="112"/>
<end position="216"/>
</location>
</feature>
<feature type="domain" description="Tyrosine-protein phosphatase" evidence="24">
<location>
<begin position="247"/>
<end position="521"/>
</location>
</feature>
<feature type="region of interest" description="Substrate binding" evidence="21">
<location>
<begin position="463"/>
<end position="469"/>
</location>
</feature>
<feature type="active site" description="Phosphocysteine intermediate">
<location>
<position position="463"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="21">
<location>
<position position="429"/>
</location>
</feature>
<feature type="binding site" description="Substrate" evidence="21">
<location>
<position position="510"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylthreonine" evidence="18">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="19">
<location>
<position position="62"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="22">
<location>
<position position="66"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by PDGFR" evidence="22">
<location>
<position position="546"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by PDGFR" evidence="19 20">
<location>
<position position="584"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 3." id="VSP_016672" evidence="84 85 86 87 88 89 90">
<location>
<begin position="408"/>
<end position="411"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_016673" evidence="86 90">
<original>S</original>
<variation>R</variation>
<location>
<position position="464"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_016674" evidence="86 90">
<location>
<begin position="465"/>
<end position="597"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; dbSNP:rs267606990." id="VAR_027183" evidence="45">
<original>T</original>
<variation>I</variation>
<location>
<position position="2"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; dbSNP:rs397507501." id="VAR_015601" evidence="36 45">
<original>T</original>
<variation>A</variation>
<location>
<position position="42"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; dbSNP:rs397507506." id="VAR_027184" evidence="41">
<original>N</original>
<variation>K</variation>
<location>
<position position="58"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; dbSNP:rs886043790." id="VAR_066060" evidence="65">
<original>T</original>
<variation>A</variation>
<location>
<position position="59"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; dbSNP:rs397507509." id="VAR_015602" evidence="36">
<original>G</original>
<variation>A</variation>
<location>
<position position="60"/>
</location>
</feature>
<feature type="sequence variant" description="In myelodysplastic syndrome; dbSNP:rs397507509." id="VAR_015990" evidence="42">
<original>G</original>
<variation>V</variation>
<location>
<position position="60"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; dbSNP:rs121918461." id="VAR_015603" evidence="35 36 38 41">
<original>D</original>
<variation>G</variation>
<location>
<position position="61"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; dbSNP:rs397507510." id="VAR_015604" evidence="36 41">
<original>D</original>
<variation>N</variation>
<location>
<position position="61"/>
</location>
</feature>
<feature type="sequence variant" description="In JMML; also in myelodysplastic syndrome; dbSNP:rs121918461." id="VAR_015991" evidence="42">
<original>D</original>
<variation>V</variation>
<location>
<position position="61"/>
</location>
</feature>
<feature type="sequence variant" description="In JMML; dbSNP:rs397507510." id="VAR_015992" evidence="42">
<original>D</original>
<variation>Y</variation>
<location>
<position position="61"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; also in Noonan patients manifesting juvenile myelomonocytic leukemia; dbSNP:rs121918460." id="VAR_015605" evidence="36 39 42 45">
<original>Y</original>
<variation>D</variation>
<location>
<position position="62"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; dbSNP:rs121918459." id="VAR_015606" evidence="35 36 38 39 41 45">
<original>Y</original>
<variation>C</variation>
<location>
<position position="63"/>
</location>
</feature>
<feature type="sequence variant" description="In JMML; also in myelodysplastic syndrome; dbSNP:rs397507511." id="VAR_015993" evidence="42">
<original>E</original>
<variation>K</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; dbSNP:rs397507511." id="VAR_027185" evidence="41">
<original>E</original>
<variation>Q</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="sequence variant" description="In acute myeloid leukemia; requires 2 nucleotide substitutions." id="VAR_015994" evidence="42">
<original>F</original>
<variation>K</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="sequence variant" description="In myelodysplastic syndrome; dbSNP:rs397507512." id="VAR_015995" evidence="41 42">
<original>F</original>
<variation>L</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; dbSNP:rs121918454." id="VAR_015607" evidence="35 36 45">
<original>A</original>
<variation>G</variation>
<location>
<position position="72"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; dbSNP:rs121918453." id="VAR_015608" evidence="35 38 41">
<original>A</original>
<variation>S</variation>
<location>
<position position="72"/>
</location>
</feature>
<feature type="sequence variant" description="In JMML; dbSNP:rs121918453." id="VAR_015996" evidence="42">
<original>A</original>
<variation>T</variation>
<location>
<position position="72"/>
</location>
</feature>
<feature type="sequence variant" description="In JMML; dbSNP:rs121918454." id="VAR_015997" evidence="42">
<original>A</original>
<variation>V</variation>
<location>
<position position="72"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; also in Noonan patients manifesting juvenile myelomonocytic leukemia; dbSNP:rs121918462." id="VAR_015609" evidence="36 38 41 42">
<original>T</original>
<variation>I</variation>
<location>
<position position="73"/>
</location>
</feature>
<feature type="sequence variant" description="In JMML; also in myelodysplastic syndrome; dbSNP:rs121918465." id="VAR_015998" evidence="42">
<original>E</original>
<variation>A</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; dbSNP:rs397507514." id="VAR_015610" evidence="35 36 41">
<original>E</original>
<variation>D</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="sequence variant" description="In JMML; dbSNP:rs121918465." id="VAR_015999" evidence="42">
<original>E</original>
<variation>G</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="sequence variant" description="In JMML; increases protein tyrosine phosphatase activity against CDC73; dbSNP:rs121918464." id="VAR_016000" evidence="42 74">
<original>E</original>
<variation>K</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="sequence variant" description="In JMML; dbSNP:rs121918465." id="VAR_016001" evidence="42">
<original>E</original>
<variation>V</variation>
<location>
<position position="76"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1." id="VAR_027186" evidence="45">
<original>Q</original>
<variation>P</variation>
<location>
<position position="79"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; dbSNP:rs121918466." id="VAR_015611" evidence="35 36 40 41">
<original>Q</original>
<variation>R</variation>
<location>
<position position="79"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; dbSNP:rs397507517." id="VAR_015612" evidence="36 45">
<original>D</original>
<variation>A</variation>
<location>
<position position="106"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; dbSNP:rs397507520." id="VAR_015613" evidence="36 41">
<original>E</original>
<variation>D</variation>
<location>
<position position="139"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; dbSNP:rs397507523." id="VAR_027187" evidence="41">
<original>Q</original>
<variation>R</variation>
<location>
<position position="256"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; increases MAPK signaling; increases protein tyrosine phosphatase activity; changed substrate selectivity for GAB1; dbSNP:rs397507525." id="VAR_078101" evidence="75">
<original>L</original>
<variation>F</variation>
<location>
<position position="261"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; increases MAPK signaling; increased protein tyrosine phosphatase activity; dbSNP:rs765642157." id="VAR_078102" evidence="75">
<original>L</original>
<variation>H</variation>
<location>
<position position="261"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; increases MAPK signaling; increased protein tyrosine phosphatase activity." id="VAR_078103" evidence="75">
<original>L</original>
<variation>F</variation>
<location>
<position position="262"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; increases MAPK signaling; increased protein tyrosine phosphatase activity; dbSNP:rs397507526." id="VAR_078104" evidence="75">
<original>L</original>
<variation>R</variation>
<location>
<position position="262"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; increases MAPK signaling; increased protein tyrosine phosphatase activity; dbSNP:rs376607329." id="VAR_078105" evidence="75">
<original>R</original>
<variation>Q</variation>
<location>
<position position="265"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1 and LPRD1; does not affect subcellular location; decreases protein tyrosine phosphatase activity against CDC73; dbSNP:rs121918456." id="VAR_015614" evidence="36 37 45 50 53 57 74">
<original>Y</original>
<variation>C</variation>
<location>
<position position="279"/>
</location>
</feature>
<feature type="sequence variant" description="In LPRD1; dbSNP:rs121918456." id="VAR_027188" evidence="50 53">
<original>Y</original>
<variation>S</variation>
<location>
<position position="279"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; dbSNP:rs397507529." id="VAR_015615" evidence="35 36 41">
<original>I</original>
<variation>V</variation>
<location>
<position position="282"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; dbSNP:rs397507531." id="VAR_015617" evidence="36">
<original>F</original>
<variation>L</variation>
<location>
<position position="285"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; dbSNP:rs121918463." id="VAR_015616" evidence="36 38">
<original>F</original>
<variation>S</variation>
<location>
<position position="285"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; common mutation; dbSNP:rs28933386." id="VAR_015619" evidence="35 36 38 41 45">
<original>N</original>
<variation>D</variation>
<location>
<position position="308"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; some patients also manifest giant cell lesions of bone and soft tissue; dbSNP:rs121918455." id="VAR_015618" evidence="36 45">
<original>N</original>
<variation>S</variation>
<location>
<position position="308"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; unknown pathological significance; dbSNP:rs201787206." id="VAR_015620" evidence="36">
<original>I</original>
<variation>V</variation>
<location>
<position position="309"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; dbSNP:rs121918467." id="VAR_027189" evidence="51">
<original>T</original>
<variation>M</variation>
<location>
<position position="415"/>
</location>
</feature>
<feature type="sequence variant" description="In LPRD1; dbSNP:rs121918468." id="VAR_027190" evidence="52">
<original>A</original>
<variation>T</variation>
<location>
<position position="465"/>
</location>
</feature>
<feature type="sequence variant" description="In LPRD1; dbSNP:rs121918469." id="VAR_027191" evidence="50 52">
<original>G</original>
<variation>A</variation>
<location>
<position position="468"/>
</location>
</feature>
<feature type="sequence variant" description="In LPRD1; does not affect subcellular location; decreases protein tyrosine phosphatase activity against CDC73; dbSNP:rs121918457." id="VAR_015621" evidence="37 45 50 53 74">
<original>T</original>
<variation>M</variation>
<location>
<position position="472"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; increased phosphatase activity; dbSNP:rs397507539." id="VAR_071706" evidence="73">
<original>P</original>
<variation>S</variation>
<location>
<position position="495"/>
</location>
</feature>
<feature type="sequence variant" description="In LPRD1; dbSNP:rs397507542." id="VAR_027192" evidence="50">
<original>R</original>
<variation>L</variation>
<location>
<position position="502"/>
</location>
</feature>
<feature type="sequence variant" description="In LPRD1; reduced phosphatase activity; dbSNP:rs397507541." id="VAR_027193" evidence="50 73">
<original>R</original>
<variation>W</variation>
<location>
<position position="502"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; dbSNP:rs397507543." id="VAR_015622" evidence="36">
<original>R</original>
<variation>K</variation>
<location>
<position position="505"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; dbSNP:rs121918458." id="VAR_015623" evidence="39 43">
<original>S</original>
<variation>T</variation>
<location>
<position position="506"/>
</location>
</feature>
<feature type="sequence variant" description="In JMML; dbSNP:rs397507546." id="VAR_016002" evidence="42">
<original>G</original>
<variation>A</variation>
<location>
<position position="507"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1 and JMML; JMML patient also shows growth retardation and pulmonic stenosis; dbSNP:rs397507545." id="VAR_016003" evidence="42 45">
<original>G</original>
<variation>R</variation>
<location>
<position position="507"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; dbSNP:rs397507547." id="VAR_015624" evidence="35 36 45">
<original>M</original>
<variation>V</variation>
<location>
<position position="508"/>
</location>
</feature>
<feature type="sequence variant" description="In LPRD1; does not affect subcellular location; decreases protein tyrosine phosphatase activity against CDC73; dbSNP:rs397509345." id="VAR_027194" evidence="48 50 54 74">
<original>Q</original>
<variation>P</variation>
<location>
<position position="510"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1." id="VAR_027195" evidence="56">
<original>Q</original>
<variation>R</variation>
<location>
<position position="510"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1 and LPRD1; does not affect subcellular location; decreases protein tyrosine phosphatase activity against CDC73; dbSNP:rs397507549." id="VAR_076499" evidence="55 58 74">
<original>Q</original>
<variation>E</variation>
<location>
<position position="514"/>
</location>
</feature>
<feature type="sequence variant" description="In LPRD1; dbSNP:rs121918470." id="VAR_027196" evidence="53">
<original>Q</original>
<variation>P</variation>
<location>
<position position="514"/>
</location>
</feature>
<feature type="sequence variant" description="In NS1; dbSNP:rs397516797." id="VAR_027197" evidence="45">
<original>L</original>
<variation>F</variation>
<location>
<position position="564"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphatase activity." evidence="80">
<original>C</original>
<variation>S</variation>
<location>
<position position="463"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAA02740." ref="3" evidence="91">
<original>S</original>
<variation>R</variation>
<location>
<position position="539"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAA02740." ref="3" evidence="91">
<original>S</original>
<variation>P</variation>
<location>
<position position="552"/>
</location>
</feature>
<feature type="turn" evidence="17">
<location>
<begin position="4"/>
<end position="6"/>
</location>
</feature>
<feature type="helix" evidence="15">
<location>
<begin position="13"/>
<end position="23"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="28"/>
<end position="33"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="35"/>
<end position="37"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="41"/>
<end position="47"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="50"/>
<end position="57"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="59"/>
<end position="61"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="63"/>
<end position="65"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="70"/>
<end position="73"/>
</location>
</feature>
<feature type="helix" evidence="15">
<location>
<begin position="74"/>
<end position="82"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="83"/>
<end position="85"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="87"/>
<end position="90"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="91"/>
<end position="93"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="107"/>
<end position="109"/>
</location>
</feature>
<feature type="strand" evidence="14">
<location>
<begin position="113"/>
<end position="116"/>
</location>
</feature>
<feature type="helix" evidence="15">
<location>
<begin position="119"/>
<end position="129"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="134"/>
<end position="139"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="141"/>
<end position="143"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="147"/>
<end position="153"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="154"/>
<end position="156"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="166"/>
<end position="175"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="178"/>
<end position="184"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="187"/>
<end position="189"/>
</location>
</feature>
<feature type="helix" evidence="15">
<location>
<begin position="190"/>
<end position="199"/>
</location>
</feature>
<feature type="strand" evidence="13">
<location>
<begin position="202"/>
<end position="204"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="208"/>
<end position="210"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="218"/>
<end position="222"/>
</location>
</feature>
<feature type="helix" evidence="15">
<location>
<begin position="223"/>
<end position="225"/>
</location>
</feature>
<feature type="helix" evidence="15">
<location>
<begin position="226"/>
<end position="234"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="251"/>
<end position="253"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="256"/>
<end position="258"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="259"/>
<end position="262"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="266"/>
<end position="269"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="271"/>
<end position="276"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="277"/>
<end position="279"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="286"/>
<end position="288"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="289"/>
<end position="291"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="304"/>
<end position="310"/>
</location>
</feature>
<feature type="strand" evidence="12">
<location>
<begin position="319"/>
<end position="321"/>
</location>
</feature>
<feature type="helix" evidence="14">
<location>
<begin position="323"/>
<end position="325"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="327"/>
<end position="331"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="335"/>
<end position="337"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="338"/>
<end position="347"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="352"/>
<end position="355"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="359"/>
<end position="361"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="364"/>
<end position="366"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="376"/>
<end position="380"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="383"/>
<end position="392"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="394"/>
<end position="405"/>
</location>
</feature>
<feature type="helix" evidence="16">
<location>
<begin position="413"/>
<end position="415"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="417"/>
<end position="424"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="429"/>
<end position="431"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="434"/>
<end position="436"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="437"/>
<end position="451"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="459"/>
<end position="467"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="468"/>
<end position="486"/>
</location>
</feature>
<feature type="strand" evidence="15">
<location>
<begin position="488"/>
<end position="492"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="494"/>
<end position="502"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="512"/>
<end position="528"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="585"/>
<end position="589"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2SHP"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3B7O"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3TKZ"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3ZM0"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3ZM1"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4DGX"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4JEG"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4JMG"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4NWG"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4OHD"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4PVG"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4RDD"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5DF6"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5EHP"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5EHR"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5I6V"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5X7B"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000250"/>
<evidence key="22" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P35235"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P41499"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00160"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00191"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10044"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10068651"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10209036"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10655584"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10681522"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11162587"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11389028"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11414741"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11433379"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11704759"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11992261"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12058348"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12161469"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12325025"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12529711"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12634870"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12717436"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12739139"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1280823"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12960218"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12972546"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14597715"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14961557"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15102829"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15121796"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15384080"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15389709"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15520399"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15690106"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15889278"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15948193"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16679933"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16733669"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16885344"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16956752"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17213291"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18559669"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18604210"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18829466"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19020799"/>
</source>
</evidence>
<evidence key="66" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19342684"/>
</source>
</evidence>
<evidence key="67" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19509291"/>
</source>
</evidence>
<evidence key="68" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19843936"/>
</source>
</evidence>
<evidence key="69" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20170098"/>
</source>
</evidence>
<evidence key="70" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20494825"/>
</source>
</evidence>
<evidence key="71" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20577567"/>
</source>
</evidence>
<evidence key="72" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23112346"/>
</source>
</evidence>
<evidence key="73" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24891296"/>
</source>
</evidence>
<evidence key="74" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26742426"/>
</source>
</evidence>
<evidence key="75" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28074573"/>
</source>
</evidence>
<evidence key="76" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7681217"/>
</source>
</evidence>
<evidence key="77" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7681589"/>
</source>
</evidence>
<evidence key="78" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7691811"/>
</source>
</evidence>
<evidence key="79" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8041791"/>
</source>
</evidence>
<evidence key="80" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8216283"/>
</source>
</evidence>
<evidence key="81" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8810330"/>
</source>
</evidence>
<evidence key="82" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9062191"/>
</source>
</evidence>
<evidence key="83" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9600074"/>
</source>
</evidence>
<evidence key="84" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1280823"/>
</source>
</evidence>
<evidence key="85" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="86" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="87" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7681217"/>
</source>
</evidence>
<evidence key="88" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="7681589"/>
</source>
</evidence>
<evidence key="89" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8216283"/>
</source>
</evidence>
<evidence key="90" type="ECO:0000303">
<source ref="6"/>
</evidence>
<evidence key="91" type="ECO:0000305"/>
<sequence length="597" mass="68436" checksum="37E8BFC7ECA2D03F" modified="2005-12-20" version="2">
MTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTG
DYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGK
EAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYD
VGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETT
DKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEP
VSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEV
ERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQALLQGNTERTVW
QYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILI
DIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQRRIEEEQKSK
RKGHEYTNIKYSLADQTSGDQSPLPPCTPTPPCAEMREDSARVYENVGLMQQQKSFR
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>